Effect of epitope flanking residues on the presentation of N-terminal cytotoxic T lymphocyte epitopes

European Journal of Immunology

Volumn 29, Issue 7, 1999, Pages 2213-2222

  Gileadi, Uzi ^a   Gallimore, Awen ^b   Van Der Bruggen, Pierre ^b   Cerundolo, Vincenzo ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

Amino terminus; Antigen presentation; MHC class I; Post translation modification

Indexed keywords

EPITOPE; VIRUS NUCLEOPROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CYTOTOXIC T LYMPHOCYTE; ELECTROPHORETIC MOBILITY; FEMALE; INFLUENZA VIRUS; ISOELECTRIC FOCUSING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES; FEMALE; MICE; MICE, INBRED C57BL; MUTATION; T-LYMPHOCYTES, CYTOTOXIC; VACCINIA VIRUS;

EID: 0033000843     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199907)29:07<2213::AID-IMMU2213>3.0.CO;2-8     Document Type: Article

References (35)

1. Heemels, M. T. and Ploegh, H. L., Generation, translocation, and presentation of MHC class 1-restricted peptides. Annu. Rev. Biochem. 1995. 64: 463-491.
2. Heemels, M. T. and Ploegh, H. L., Substrate specificity of allelic variants of the TAP peptide transporter. Immunity 1994. 1: 775-784.
3. Momburg, F., Roelse, J., Howard, J. C., Butcher, G. W., Hämmerling, G. J. and Neefjes, J. J., Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 1994. 367: 648-651.
4. Pamer, E. and Cresswell, P., Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 1998. 16: 323-358.
5. Vinitsky, A., Anton, L. C., Snyder, H. L., Orlowski, M., Bennink, J. R. and Yewdell, J. W., The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing? J. Immunol. 1997. 159: 554-564.
6. Antón, L. C., Snyder, H. L., Bennink, J. R., Vinitsky, A., Orlowski, M., Porgador, A. and Yewdell, J. W., Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides. J. Immunol. 1998. 160: 4589-4868.
7. Glas, R., Bogyo, M., McMaster, J. S., Gaczynska, M. and Ploegh, H. L., A proteolytic system that compensates for loss of proteasome function. Nature 1998. 392: 618-622.
8. Luckey, C. J., King, G. M., Marto, J. A., Venketeswaran, S., Maier, B. F., Crotzer, V. L., Colella, T. A., Shabanowitz, J., Hunt, D. F. and Engelhard, V. H., Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. J. Immunol. 1998. 161: 112-121.
9. Coux, O., Tanaka, K. and Goldberg, A. L., Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65: 801-847.
10. Orlowski, M., Cardozo, C. and Michaud, C., Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry 1993. 32:1563-1572.
11. Theobald, M., Ruppert, T., Kuckelkorn, U., Hernandez, J., Haussler, A., Ferreira, E. A., Liewer, U., Biggs, J., Levine, A. J., Huber, C., Koszinowski, U. H., Kloetzel, P. M. and Sherman, L. A., The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope. J. Exp. Med. 1998. 188: 1017-1028.
12. Eggers, M., Boes, F. B., Ruppert, T., Kloetzel, P. M. and Koszinowski, U. H., The cleavage preference of the proteasome governs the yield of antigenic peptides. J. Exp. Med. 1995. 182: 1865-1870.
13. Bergmann, C. C., Yao, Q., Ho, C. K. and Buckwold, S. L., Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes. J. Immunol. 1996. 157: 3242-3249.
14. Yellen Shaw, A. J. and Eisenlohr, L. C., Regulation of class I-restricted epitope processing by local or distal flanking sequence. J. Immunol. 1997. 158: 1727-1733.
15. Yellen-Shaw, A. J., Wherry, E. J., Dubois, G. C. and Eisenlohr, L. C., Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of full-length viral protein. J. Immunol. 1997. 158: 3227-3234.
16. Del-Val, M., Schlicht, H. J., Ruppert, T., Reddehase, M. J. and Koszinowski, U. H., Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 1991. 66: 1145-1153.
17. Niedermann, G., Butz, S., Ihlenfeldt, H. G., Grimm, R., Lucchiari, M., Hoschutzky, H., Jung, G., Maier, B. and Eichmann, K., Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 1995. 2: 289-299.
18. Valmori, D., Gileadi, U., Servis, C., Dunbar, P. R., Cerottini, J. C., Romero, P., Cerundolo, V. and Lévy, F., Modulation of proteasomal activity required for the generation of a CTL-defined peptide derived from the tumor antigen MAGE-3. J. Exp. Med. 1999. 189: 895-905.
19. Hershko, A. and Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 1998. 67: 425-479.
20. Michalek, M. T., Grant, E. P., Gramm, C., Goldberg, A. L. and Rock, K. L., A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 1993. 363: 552-554.
21. Cox, J. H., Galardy, P., Bennink, J. R. and Yewdell, J. W., Presentation of endogenous and exogenous antigens is not affected by inactivation of E1 ubiquitin-activating enzyme in temperature-sensitive cell lines. J. Immunol. 1995. 154: 511-519.
22. Skipper, J. C., Hendrickson, R. C., Gulden, P. H., Brichard V., Van Pel, A., Chen, Y., Shabanowitz, J., Wolfel, T., Slingluff, C. J., Boon, T., Hunt, D. F. and Engelhard, V. H., An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med. 1996. 183: 527-534.
23. Meadows, L., Wang, W., den Haan, J. M. M. Blokland, E., Reinhardus, C., Drijfhout, J. W., Shabanowitz, J., Pierce, R., Agulnik, A. I., Bishop, C. E., Hunt, D. F., Goulmy, E. and Engelhard, V. H., The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 1997. 6: 273-281.
24. Wood, P. and Elliott, T., Glycan-regulated antigen processing of a protein in the endoplasmic reticulum can uncover cryptic cytotoxic T cell epitopes J. Exp. Med. 1998. 188: 733-778.
25. Bouvier, M. and Wiley, D. C., Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science 1994. 265: 398-402.
26. Elliott, T., Elvin, J., Cerundolo, V., Allen, H. and Townsend, A., Structural requirements for the peptide-induced conformational change of free major histocompatibility complex class I heavy chains. Eur. J. Immunol. 1992. 22: 2085-2091.
27. Brown, J. L. and Roberts, W. K., Evidence that approximately eights per cent of the soluble proteins from Ehrlich ascites cells are N-alpha-acetylated. J. Biol. Chem. 1976. 251: 1009-1014.
28. Boel, P., Wildmann, C., Sensi, M. L., Brasseur, R., Renauld, J. C., Coulie, P., Boon, T. and Van der Bruggen, P., BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995. 2: 167-175.
29. Elliott, T., Willis, A., Cerundolo, V. and Townsend, A., Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 1995. 181: 1481-1491.
30. Anton, L. C., Yewdell, J. W. and Bennink, J. R., MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J. Immunol. 1997. 158: 2535-2542.
31. Cerundolo, V., Alexander, J., Anderson, K., Lamb, C., Cresswell, P., McMichael, A., Gotch, F. and Townsend, A., Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature 1990. 345: 449-452.
32. Townsend, A. R., Rothbard, J., Gotch, F. M., Bahadur, G., Wraith, D. and McMichael, A. J., The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986. 44: 959-968.
33. Cerundolo, V., Kelly, A., Elliott, T., Trowsdale, J. and Townsend, A., Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport Eur. J. Immunol. 1995. 25: 554-562.
34. Townsend, A., Bastin, J., Gould, K., Brownlee, G., Andrew, M., Coupar, B., Boyle, D., Chan, S. and Smith, G., Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 1988. 168: 1211-1224.
35. Townsend, A. R. and Skehel, J. J., The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells. J. Exp. Med. 1984. 160: 552-563.